US8162123025 - RNAC - A407YS (XNMS)
CARTESIAN THERAP. NEW Aktie
14,82 EUR
Aktuelle Kurse von CARTESIAN THERAP. NEW
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
RNAC
|
USD
|
19.09.2024 22:00
|
16,54 USD
| 15,63 USD | 5,82 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -2,08 % | 13,31 % | -26,93 % | -24,84 % | -51,12 % | -70,01 % |
Firmenprofil zu CARTESIAN THERAP. NEW Aktie
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.
Unternehmensdaten zur CARTESIAN THERAP. NEW Aktie
Name CARTESIAN THERAP. NEW
Firma Cartesian Therapeutics, Inc.
Symbol RNAC
Website https://selectabio.com
Heimatbörse
Frankfurt
WKN A407YS
ISIN US8162123025
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Carsten Brunn Ph.D.
Marktkapitalisierung 298 Mio
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 65 Grove Street, 02472 Watertown
IPO Datum 2016-06-22
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
14.11.2023 | SELB | RNAC |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 1S70.F |
NASDAQ | RNAC |
Weitere Aktien
Investoren die CARTESIAN THERAP. NEW halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024